Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CAMRF - Ra Pharma in-licenses technology for long-acting zilucoplan

CAMRF - Ra Pharma in-licenses technology for long-acting zilucoplan

Camurus AB
  • Ra Pharmaceuticals (NASDAQ:RARX) inks a global license agreement with Camurus AB (OTC:CAMRF) securing the rights to the latter's FluidCrystal technology that will enable the development of a long-acting formulation of C5 inhibitor zilucoplan for the treatment of complement-mediated disorders.
  • More news on: Ra Pharmaceuticals, Inc., Camurus AB (publ), Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Camurus AB
Stock Symbol: CAMRF
Market: OTC
Menu
CAMRF CAMRF Quote CAMRF Short CAMRF News CAMRF Articles CAMRF Message Board
Get CAMRF Alerts

News, Short Squeeze, Breakout and More Instantly...